4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000008
GENERAL COUNSEL & CORP SEC sold 9,293 shares at an average $33.69 ($313,038)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-20 | Sale 10b5-1 | −8,692 | $33.64 | $292,359 | 20,144 | D: show line 1 in the form |
| Allan Jonathan GENERAL COUNSEL & CORP SEC | 2026-03-20 | Sale 10b5-1 | −601 | $34.41 | $20,679 | 19,543 | D: show line 2 in the form |
| Open-market sales · 9,293 sh · avg $33.69 · $313,038 | |||||||
Loading xslF345X06/form4-03242026_080316.xml…